Actionable news
All posts from Actionable news
Actionable news in PTCT: PTC Therapeutics, Inc.,

Perilous Reversal Stock: PTC Therapeutics (PTCT)

Trade-Ideas LLC identified PTC Therapeutics ( PTCT) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified PTC Therapeutics as such a stock due to the following factors:

  • PTCT has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $25.9 million.
  • PTCT has traded 145,424 shares today.
  • PTCT is down 3.4% today.
  • PTCT was up 10.4% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in PTCT with the Ticky from Trade-Ideas. See the FREE profile for PTCT NOW at Trade-Ideas More details on PTCT: PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. Currently there are 7 analysts that rate PTC Therapeutics a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for PTC Therapeutics has been 714,500 shares per day over the past 30 days. PTC has a market cap of $931.5 million and is part of the health care sector and drugs industry. The stock has a beta of -0.45 and a short float of 21.1% with 6.22 days to cover...